GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » Total Equity

Hangzhou AGS Medtech Co (SHSE:688581) Total Equity : ¥2,242.1 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co Total Equity?

Hangzhou AGS Medtech Co's total equity for the quarter that ended in Mar. 2024 was ¥2,242.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Hangzhou AGS Medtech Co Total Equity Historical Data

The historical data trend for Hangzhou AGS Medtech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou AGS Medtech Co Total Equity Chart

Hangzhou AGS Medtech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 171.59 216.69 271.45 381.54 2,208.24

Hangzhou AGS Medtech Co Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 415.80 2,067.49 2,132.31 2,208.24 2,242.06

Hangzhou AGS Medtech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Hangzhou AGS Medtech Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=2331.074-122.835
=2,208.2

Hangzhou AGS Medtech Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=2329.419-87.363
=2,242.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou AGS Medtech Co Total Equity Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou AGS Medtech Co (SHSE:688581) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » Total Equity
Comparable Companies
SZSE:300143 SZSE:300206 SHSE:688108 SHSE:603387 SHSE:688298 SHSE:688085 SZSE:301087 SZSE:002932 SHSE:688626 SZSE:300318 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106
Website
http://www.bioags.com
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.

Hangzhou AGS Medtech Co (SHSE:688581) Headlines

No Headlines